OPEN

Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment

Uthaug, M. V., Lancelotta, R., Szabo, A., Davis, A. K., Riba, J., & Ramaekers, J. G. | Psychopharmacology | 10 December 2019

By OPEN|2020-02-24T19:55:21+02:0010 December 2019|Tags: A. Davis, A. Szabo, J. Ramaekers, J. Riba, M. Uthaug, R. Lancelotta|

Neuropharmacological modulation of the aberrant bodily self through psychedelics

Ho, J. T., Preller, K. H., & Lenggenhager, B. | Neuroscience & Biobehavioral Reviews | 6 December 2019

By OPEN|2020-01-16T15:47:23+02:006 December 2019|Tags: B. Lenggenhager, J. Ho, K. Preller|

Modulation of Social Cognition via Hallucinogens and “Entactogens”.

Preller, K. H., & Vollenweider, F. X. | Frontiers in Psychiatry | 3 December 2019

By OPEN|2020-01-07T14:12:37+02:003 December 2019|Tags: F. Vollenweider, K. Preller|

Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.

dos Santos, R. G., & Hallak, J. E. C. | Neuroscience & Biobehavioral Reviews | 3 December 2019

By OPEN|2019-12-28T11:52:30+02:003 December 2019|Tags: J. Hallak, R. dos Santos|

Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.

Moreton, S. G., Szalla, L., Menzies, R. E., & Arena, A. F. | Psychopharmacology | 29 November 2019

By OPEN|2019-12-11T21:06:30+02:0029 November 2019|Tags: A. Arena, L. Szalla, R. Menzies, S. Moreton|

Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.

Andersson, M., & Kjellgren, A. | Harm reduction journal | 28 November 2019

By OPEN|2019-12-14T13:28:38+02:0028 November 2019|Tags: A. Kjellgren, M. Andersson|

Microdosing psychedelics: Motivations, subjective effects and harm reduction.

Lea, T., Amada, N., Jungaberle, H., Schecke, H., & Klein, M. | International Journal of Drug Policy | 25 November 2019

By OPEN|2019-12-14T13:18:35+02:0025 November 2019|Tags: H. Jungaberle, H. Schecke, M. Klein, N. Amanda, T. Lea|

Psilocybin-assisted therapy for depression: How do we advance the field?

Meikle, S. E., Liknaitzky, P., Rossell, S. L., Ross, M., Strauss, N., Thomas, N., ... & Castle, D. J. | Australian & New Zealand Journal of Psychiatry | 22 November 2019

By OPEN|2019-12-01T21:13:37+02:0022 November 2019|Tags: D. Castle, M. Ross, N. Strauss, N. Thomas, P. Liknaitzky, S. Meikle, S. Rossel|

The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial.

Zeifman, R., Palhano-Fontes, F., Hallak, J., Nunes, E. A., Maia-de-Oliveira, J. P., & de Araujo, D. B. | Frontiers in Pharmacology | 19 November 2019

By OPEN|2019-12-28T12:01:23+02:0019 November 2019|Tags: D. de Araujo, E. Nunes, F. Palhano-Fontes, J. Hallak, J. Maia-de-Oliveira, R. Zeifman|

Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.

Holze, F., Vizeli, P., Müller, F., Ley, L., Duerig, R., Varghese, N., ... & Liechti, M. E. | Neuropsychopharmacology | 16 November 2019

By OPEN|2019-12-18T11:53:02+02:0016 November 2019|Tags: F. Holze, F. Müller, L. Ley, N. Varghese, P. Vizeli, R. Duerig|